Allergy Therapeutics Plc is a biotechnology company, which engages in the Research and Development of allergy treatments. The company was founded by Keith Iain Carter in 1998 and is headquartered in Worthing, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AGYTF is 0.0520 USD — it has decreased by −13.33% in the past 24 hours. Watch Allergy Therapeutics Plc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Allergy Therapeutics Plc. stocks are traded under the ticker AGYTF.
We've gathered analysts' opinions on Allergy Therapeutics Plc. future price: according to them, AGYTF price has a max estimate of 0.17 USD and a min estimate of 0.17 USD. Watch AGYTF chart and read a more detailed Allergy Therapeutics Plc. stock forecast: see what analysts think of Allergy Therapeutics Plc. and suggest that you do with its stocks.
AGYTF reached its all-time high on Nov 4, 2021 with the price of 0.5390 USD, and its all-time low was 0.0001 USD and was reached on Oct 21, 2020. View more price dynamics on AGYTF chart. See other stocks reaching their highest and lowest prices.
AGYTF stock is 15.38% volatile and has beta coefficient of −0.17. Track Allergy Therapeutics Plc. stock price on the chart and check out the list of the most volatile stocks — is Allergy Therapeutics Plc. there?
Today Allergy Therapeutics Plc. has the market capitalization of 375.65 M, it has increased by 0.84% over the last week.
Allergy Therapeutics Plc. is going to release the next earnings report on Mar 5, 2025. Keep track of upcoming events with our Earnings Calendar.
AGYTF net income for the last half-year is −31.06 M USD, while the previous report showed −19.92 M USD of net income which accounts for −55.88% change. Track more Allergy Therapeutics Plc. financial stats to get the full picture.
No, AGYTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 9, 2025, the company has 612.00 employees. See our rating of the largest employees — is Allergy Therapeutics Plc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Allergy Therapeutics Plc. EBITDA is −39.48 M USD, and current EBITDA margin is −56.93%. See more stats in Allergy Therapeutics Plc. financial statements.
Like other stocks, AGYTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Allergy Therapeutics Plc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Allergy Therapeutics Plc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Allergy Therapeutics Plc. stock shows the sell signal. See more of Allergy Therapeutics Plc. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.